Answers are grounded in this paper and cite their sources.
Prospective observational study links serum lactate dehydrogenase and albumin levels to severity in acute pancreatitis, suggesting clinical integration.
Background: Acute pancreatitis (AP) is an inflammatory disease with varied presentations, ranging from mild self-limiting episodes to severe, life-threatening conditions. Timely identification of severe cases is crucial. Objective: This study aimed to determine the significance of serum lactate dehydrogenase (LDH) and albumin levels in assessing the severity of acute pancreatitis. Methods: A prospective observational study was conducted on 66 patients diagnosed with AP based on the Revised Atlanta Criteria (2012). Serum LDH and albumin levels were measured within 24 hours of admission and correlated with severity indicators such as BISAP, Ranson's, and APACHE II scores. Results:Elevated LDH (>250 U/L) and hypoalbuminemia (<3.5 g/dL) were significantly associated with severe AP. Among patients with LDH >500 U/L, 100% had severe disease. Patients with serum albumin <3.0 g/dL were predominantly in the severe category. These findings highlight the predictive value of these markers. Conclusion: Serum LDH and albumin are simple, accessible biomarkers that provide valuable early insights into the severity of acute pancreatitis. Incorporating them into routine clinical practice can improve outcomes, especially in resource-constrained settings.
No takes yet. Share an insight, caveat, or question.
Rahul et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: